Cecilia Leung
VP of Research Vivatides Therapeutics
Seminars
Wednesday 9th December 2026
Screening Beyond GalNAc and TFR & Identifying Which Novel Targeting Ligands Are Actually Worth Pursuing
2:15 pm
- Explore how target-agnostic ligand discovery platforms, including mRNA display and DNA-encoded libraries, are uncovering previously unexplored receptor targets for selective oligonucleotide delivery
- Understand how AI and machine learning approaches applied to real screening datasets are being used to optimise ligand properties, improve binding characteristics and enhance delivery performance
- Gain practical insights into how emerging ligand discovery technologies can be integrated into your own oligonucleotide development programmes to expand targeting opportunities beyond current approaches
